FGF21 and metabolic dysfunction-associated steatotic liver disease: Circulating FGF21 levels are highly elevated in non-alcoholic fatty liver disease (NAFLD) patients, as well as, in obese animals, suggestive of impaired FGF21 signaling18,29,30.